Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida species are the fourth most common cause of hospital-acquired bloodstream infections (BSI) in the United States (5, 9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
In the citing paper
“These species proportions are very similar to those previously reported from the northeastern United States (9).”
In the citing paper
“The National Epidemiology of Mycoses Survey study demonstrated geographic variations in species distributions throughout the United States, with C. albicans ranging from 46% in the northeast to 70% in the southwest and C. glabrata ranging from 15% in the southwest to 26% in the northeast (9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 3×
“Nonetheless, prospective surveillance projects such as ours will allow rapid detection of such infections, which initially appeared in Japan [17, 18] and have been reported in the United States [19].”
BackgroundHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 1×
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationPfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331
Self-citationCeftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationMarshall, S. A., Wilke, W. W., Pfaller, M. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00212-5 · Cited by 146
Self-citationAntimicrobial Resistance: Issues and Options
(1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 129
Cited by
Items 601–700 of 1,001
Nannini, E. C., Pai, S. R., Singh, K. V., & Murray, B. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.529-532.2003 · Cited by 39
Casaburi, G., & Frese, S. A. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.05.001 · Cited by 38
“A rising global incidence of bacteria resistant to several classes of antibiotics, limits effective therapies [6,7], and infections are a leading cause of death in infant intensive care units [8].”
BackgroundThe predictors of outcome in immunocompetent patients with hematogenous candidasis
Safdar, A., Bannister, T. W., & Safdar, Z. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.05.003 · Cited by 38
Effiziente Erkennung von Bakterien mit Goldnanopartikel‐Poly(para‐phenylenethinylen)‐Konstrukten
Phillips, R. L., Miranda, O. R., You, C., Rotello, V. M., & Bunz, U. H. F. (2008) · Angewandte Chemie · doi:10.1002/ange.200703369 · Cited by 38
Regulatory roles of phosphorylation in model and pathogenic fungi
Bataineh, M. T. A., & Kadosh, D. (2015) · Medical Mycology · doi:10.1093/mmy/myv098 · Cited by 38
Haber, J. M., Gascoyne, P. R. C., & Sokolov, K. (2017) · Lab on a Chip · doi:10.1039/c7lc00211d · Cited by 38
Mukherjee, P. K., Chand, D. V., Chandra, J., Anderson, J. M., & Ghannoum, M. A. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01632.x · Cited by 38
Doyle, T. C., Nawotka, K. A., Purchio, A. F., Akin, A. R., Francis, K. P., & Contag, P. R. (2006) · Microbial Pathogenesis · doi:10.1016/j.micpath.2005.11.002 · Cited by 38
Methicillin-resistant Staphylococcus aureus infections in ICU patients
Sista, R. R., Oda, G., & Barr, J. (2004) · Anesthesiology Clinics of North America · doi:10.1016/j.atc.2004.04.006 · Cited by 38
Jones, R. N. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.suppl_2.1 · Cited by 37
Self-citationPotentiation of Azole Antifungals by 2-Adamantanamine
LaFleur, M. D., Sun, L., Lister, I., Keating, J., Nantel, A., Long, L. A., Ghannoum, M. A., North, J., Lee, R. E., Jr., Coleman, K., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-13 · Cited by 37
Alfonso, C. P., López, M., Arechavala, A. I., Perrone, M. D. C., Guelfand, L. I., & Bianchi, M. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.01.008 · Cited by 37
Assessment of Host Defence Mechanisms Induced by Candida Species
Paoletti, I., Fusco, A., Grimaldi, E., Perillo, L., Coretti, L., Domenico, M. D., Cozza, V., Lucchese, A., Contaldo, M., Serpico, R., et al. (2013) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201302600309 · Cited by 37
Choi, S., Kim, Y. S., Chung, J.-W., Kim, T. H., Choo, E. J., Kim, M., Kim, B.-N., Kim, N. J., Woo, J. H., & Ryu, J. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502004 · Cited by 37
Candidemia in Burn Patients: Figures and Facts
Pedrosa, A. F., & Rodrigues, A. G. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181f2d4fb · Cited by 37
A Novel Actin Binding Drug withIn VivoEfficacy
Ravichandran, A., Geng, M., Hull, K. G., Li, J., Romo, D., Lu, S., Albee, A., Nutter, C., Gordon, D. M., Ghannoum, M. A., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01585-18 · Cited by 37
Nonribosomal cyclic peptides: specific markers of fungal infections
Jegorov, A., Hajdúch, M., Šulc, M., & Havlíček, V. (2006) · Journal of Mass Spectrometry · doi:10.1002/jms.1042 · Cited by 37
Safdar, A., Bryan, C. S., Stinson, M. S., & Saunders, D. E. (2002) · Clinical Infectious Diseases · doi:10.1086/340527 · Cited by 37
The Effect of an Antimicrobial Formulary Change on Hospital Resistance Patterns
Empey, K. M., Rapp, R. P., & Evans, M. E. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.1.81.33508 · Cited by 37
Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic
Corti, G., Cinelli, R., & Paradisi, F. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00290-9 · Cited by 37
Khandelwal, N., Wasi, M., Nair, R., Gupta, M., Kumar, M., Mondal, A. K., Gaur, N. A., & Prasad, R. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01347-18 · Cited by 36
Direct Identification of Gram-Positive Cocci from Routine Blood Cultures by Using AccuProbe Tests
Lindholm, L., & Sarkkinen, H. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5609-5613.2004 · Cited by 36
Xu, Y., Sheng, C., Wang, W., Che, X., Cao, Y., Dong, G., Wang, S., Ji, H., Miao, Z., Yao, J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.014 · Cited by 36
Prevention of Candida albicans Biofilm Formation
Coenye, T. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010009 · Cited by 36
Pharmacotherapy of yeast infections
Gómez‐López, A., Zaragoza, Ó., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.16.2801 · Cited by 36
Adjunctive immunotherapy with recombinant cytokines for the treatment of disseminated candidiasis
van de Veerdonk, F. L., Kullberg, B. J., & Netea, M. G. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03676.x · Cited by 36
Doğan, Ö., Yesilkaya, A., Menekşe, Ş., Güler, Ö., Karakoç, Ç., Çınar, G., Kapmaz, M., Aydın, M., Keske, Ş., Şahin, S., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105992 · Cited by 36
Rapid identification of Candida glabrata in Candida bloodstream infections
Foster, N., Symes, C., Barton, R., & Hobson, R. P. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47406-0 · Cited by 36
Bolmström, A., Ballow, C. H., Qwärnström, A., Biedenbach, D. J., & Jones, R. N. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00484.x · Cited by 36
Self-citationDecreasing rates of invasive candidiasis in pediatric hospitals across the United States.
Fisher, B. T., Ross, R. K., Localio, A. R., Prasad, P. A., & Zaoutis, T. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit679 · Cited by 35
Schofield, D. A., Westwater, C., Warner, T., Nicholas, P. J., Paulling, E. E., & Balish, E. (2003) · The Journal of Infectious Diseases · doi:10.1086/377182 · Cited by 35
Daptomycin: a new treatment for insidious infections due to gram-positive pathogens
Cottagnoud, P. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.12045 · Cited by 35
Komatsu, T., Salih, E., Helmerhorst, E. J., Offner, G. D., & Oppenheim, F. G. (2010) · Journal of Proteome Research · doi:10.1021/pr100861k · Cited by 35
Kim, S. H., Shin, J. H., Mok, J., Kim, S. Y., Song, S. A., Kim, H. R., Kook, J., Chang, Y.-H., Bae, I. K., & Lee, K. (2014) · BioMed Research International · doi:10.1155/2014/250408 · Cited by 35
Incidence and predictors of invasive candidiasis associated with candidaemia in children
Festekjian, A., & Neely, M. N. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01785.x · Cited by 35
de Almeida-Apolonio, A. A., Mesquita, C. S. S., Svidzinski, T. I. E., & de Oliveira, K. M. P. (2013) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0074-2012 · Cited by 35
Goldschmidt, P. L., Degorge, S., Sarria, P. C., Ghoubay, D., Semoun, O., Borderie, V. M., Laroche, L., & Chaumeil, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037660 · Cited by 35
Antibiotic resistance of enterococci isolated from frozen foods and environmental water.
Tansuphasiri, U., Khaminthakul, D., & Pandii, W. (2006) · PubMed · Cited by 35
A consensus statement on empiric therapy for suspected gram-positive infections in surgical patients
Solomkin, J. S., BJORNSON, H. S., Caínzos, M., Dellinger, E. P., Dominioni, L., Eidus, R., Faist, E., Leaper, D. J., Lee, J. T., Lipsett, P. A., et al. (2003) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.03.006 · Cited by 35
Catheter-Related Infections: Diagnosis and Intravascular Treatment
Bouza, E., Burillo, A., & Muñóz, P. (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.supplement-2.224 · Cited by 34
Licata, F., Quirino, A., Pepe, D., Matera, G., Bianco, A., & Collaborative Group (2020) · Antibiotics · doi:10.3390/antibiotics10010010 · Cited by 34
Guarascio, A. J., Slain, D., McKnight, R., Petros, K. O., Parker, J. E., Wilson, A. M., Defazio, C. M., & Sarwari, A. R. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9712-5 · Cited by 34
Fungal Infections in Cancer Patients
Angarone, M. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-04220-6_4 · Cited by 34
Sensitivity of clinical isolates of Candida to essential oils from Burseraceae family
Nikolić, M., Smiljkovic, M. S., Marković, T., Ćirić, A., Glamočlija, J., Markovic, D. L. J., & Sokóvić, M. (2016) · EXCLI journal · doi:10.17179/excli2014-621 · Cited by 34
Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004
Caggiano, G., Iatta, R., Laneve, A., Manca, F., & Montagna, M. T. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01452.x · Cited by 34
Use of Transthoracic Echocardiography in the Management of Low-Risk Staphylococcus aureus Bacteremia
Showler, A., Burry, L. D., Bai, A. D., Steinberg, M., Ricciuto, D. R., Fernandes, T., Chiu, A., Raybardhan, S., Science, M. E., Fernando, E., et al. (2015) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.02.027 · Cited by 34
Hageman, J. C., Fridkin, S. K., Mohammed, J. M., Steward, C. D., Gaynes, R. P., & Tenover, F. C. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502214 · Cited by 34
Increasing threat of Gram-positive bacterial infections in the intensive care unit setting
McGowan, J. E. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104001-00003 · Cited by 34
Rosa, G. D. L., León, A. L., & Jaimes, F. A. (2016) · Revista chilena de infectología · doi:10.4067/s0716-10182016000200003 · Cited by 33
Taverna, C. G., Bosco‐Borgeat, M. E., Murisengo, O. A., Davel, G., Boité, M. C., Cupolillo, E., & Canteros, C. E. (2013) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276108022013009 · Cited by 33
Management ofCandidainfections in the adult intensive care unit
Cruciani, M., & Serpelloni, G. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.175 · Cited by 33
Synthesis and antimicrobial evaluation of some new substituted purine derivatives
Tunçbilek, M., Ateş‐Alagöz, Z., Altanlar, N., Karayel, A., & Özbey, S. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.050 · Cited by 33
Fluconazole Prophylaxis in the Very Low Birth Weight Infant: Not Ready for Prime Time
Neely, M. N., & Schreiber, J. R. (2001) · PEDIATRICS · doi:10.1542/peds.107.2.404 · Cited by 33
Invasive candidiasis; a review article
Zarrin, M., & Mahmoudabadi, A. Z. (2009) · Jundishapur Journal of Microbiology · Cited by 33
Sütçü, M., Acar, M., Genç, G. E., Kökçü, İ., Aktürk, H., Atay, G., Törün, S. H., Salman, N., Erturan, Z., & Somer, A. (2017) · Türk Pediatri Arşivi · doi:10.5152/turkpediatriars.2017.5291 · Cited by 33
Assessment of silibinin as a potential antifungal agent and investigation of its mechanism of action
Yun, D. G., & Lee, D. G. (2017) · IUBMB Life · doi:10.1002/iub.1647 · Cited by 33
Li, Y., Ma, Y.-K., Zhang, L., Guo, F., Ren, L., Yang, R., Li, Y., & Lou, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035543 · Cited by 33
Cutaneous expression of systemic candidiasis
Pedraz, J., Delgado‐Jiménez, Y., Perez‐Gala, S., Nam‐Cha, S. H., Fernández‐Herrera, J., & García‐Diez, A. (2008) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2007.02524.x · Cited by 33
Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programme
Ünal, S., Masterton, R. G., & Goossens, H. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.07.003 · Cited by 33
Wisplinghoff, H., Seifert, H., Coimbra, M. V. D. S., Wenzel, R. P., & Edmond, M. B. (2001) · Clinical Infectious Diseases · doi:10.1086/322610 · Cited by 33
Self-citationMonitoring Phenotypic Switching in Candida albicans and the Use of Next‐Gen Fluorescence Reporters
Frazer, C., Hernday, A. D., & Bennett, R. J. (2019) · Current Protocols in Microbiology · doi:10.1002/cpmc.76 · Cited by 32
Kazakou, N., Vyzantiadis, T., Gambeta, A., Vasileiou, E., Tsotridou, E., Kotsos, D., Giantsidi, A., Saranti, A., Palabougiouki, M., Ioannidou, M., et al. (2020) · Current Medical Mycology · doi:10.18502/cmm.6.2.2840 · Cited by 32
Iancu, A. V., Arbune, M., ZAHARIA, E. A., Tutunaru, D., Maftei, N.-M., Peptine, L.-D., Țocu, G., & Gurău, G. (2023) · Applied Sciences · doi:10.3390/app13063866 · Cited by 32
Michán, C., & Pueyo, C. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00558.x · Cited by 32
Tak, V., Mathur, P., Lalwani, S., & Misra, M. C. (2013) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.115939 · Cited by 32
Ko, J. E., Ko, Y., Kim, W. I., Kwon, O. H., & Kwon, O. H. (2016) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33726 · Cited by 32
Tseng, T.-Y., Chen, T., Ho, C., Lin, P., Chou, C.-H., Tsai, C.-T., Wang, J.-H., Chi, C.-Y., & Ho, M. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.08.015 · Cited by 32
Alrumaihi, F., Allemailem, K. S., Almatroudi, A., Alsahli, M. A., Khan, A., & Khan, M. A. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201019666190722151126 · Cited by 32
Candida: A Causative Agent of an Emerging Infection
Ghannoum, M. A. (2001) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.0022-202x.2001.00047.x · Cited by 32
Draghi, D. C., Sheehan, D. F., Hogan, P. A., & Sahm, D. F. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.01.003 · Cited by 32
Intravenous Mouse Infection Model for Studying the Pathology of Enterococcus faecalis Infections
Gentry-Weeks, C. R., Estay, M., Loui, C., & Baker, D. C. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1434-1441.2003 · Cited by 32
Update on the appropriate use of linezolid in clinical practice
Manfredi, R. (2006) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2006.2.4.455 · Cited by 32
Osteoarticular Infection Complicating Enterococcal Endocarditis
Vlahakis, N. E., Temesgen, Z., Berbari, E. F., & Steckelberg, J. M. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.5.623 · Cited by 32
Loeffler, A. M., Drew, R. H., Perfect, J. R., GRETHE, N. I., STEPHENS, J. W., Gray, S. L., & Talbot, G. H. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00013 · Cited by 32
INVASIVE ASPERGILLOSIS IN CHILDREN: UPDATE ON CURRENT GUIDELINES
Apsemidou, A., Petridis, N., Vyzantiadis, T., & Tragiannidis, A. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.048 · Cited by 31
Childers, D. S., & Kadosh, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122775 · Cited by 31
Emerging Issues in Antibiotic Resistance in Blood-borne Infections
Karam, G. H., & Heffner, J. E. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.pc10-00 · Cited by 31
Pourakbari, B., Aghdam, M. K., Mahmoudi, S., Ashtıani, M. T. H., Sabouni, F., Movahedi, Z., Alyari, A. E., Sadeghi, R. H., & Mamishi, S. (2012) · Europe PMC (PubMed Central) · Cited by 31
Intracellular pH homeostasis in Candida glabrata in infection-associated conditions
Ullah, A., Lopes, M. I., Brul, S., & Smits, G. J. (2013) · Microbiology · doi:10.1099/mic.0.063610-0 · Cited by 31
Epidemiology and prognosis of candidaemia in elderly patients
Ramos, A., López, N. V., Sánchez‐Romero, I., Padilla, B., Amador, P. M., Garnacho‐Montero, J., Ruíz-Camps, I., Montejo, M., Salavert, M., Mensa, J., et al. (2017) · Mycoses · doi:10.1111/myc.12677 · Cited by 31
Ergül, A. B., Işik, H., Altıntop, Y. A., & Torun, Y. A. (2017) · Türk Pediatri Arşivi · doi:10.5152/turkpediatriars.2017.5451 · Cited by 31
von Baum, H., Ober, J. F., Wendt, C., Wenzel, R. P., & Edmond, M. B. (2005) · Infection · doi:10.1007/s15010-005-5066-4 · Cited by 31
Self-citationCaspofungin in Combination with Amphotericin B against Candida glabrata
Barchiesi, F., Spreghini, E., Fothergill, A. W., Arzeni, D., Greganti, G., Giannini, D., Rinaldi, M. G., & Scalise, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2546-2549.2005 · Cited by 28
Emerging Complexity and the Need for Advanced Drug Delivery in Targeting Candida Species
Wadhwa, R., Pandey, P., Gupta, G., Aggarwal, T., Kumar, N., Mehta, M., Satija, S., Gulati, M., Madan, J., Dureja, H., et al. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191026105308 · Cited by 30
Dixon, S., McKeen, E. S., Tabberer, M., & Paisley, S. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422070-00002 · Cited by 30
Staphylococcus Aureus Bacteremia Among Patients with Health Care-associated Fever
Stryjewski, M. E., Kanafani, Z. A., Chu, V. H. Y., Pappas, P. A., Harding, T. M., Drew, L. A., Benjamin, D. K., Reller, L. B., Lee, B. A., Corey, G. R., et al. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.040 · Cited by 30
Épidémiologie des candidémies : étude observationnelle prospective d’un an dans l’Ouest de la France
Talarmin, J. P., Boutoille, D., Tattevin, P., Dargère, S., Weinbreck, P., Ansart, S., Chennebault, J. M., Hutin, P., Leautez-Nainville, S., Gay‐Andrieu, F., et al. (2009) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2009.02.008 · Cited by 30
Identification and management of invasive mycoses in internal medicine: a road-map for physicians
Falcone, M., Concia, E., Iori, I., Cascio, G. L., Mazzone, A., Pea, F., Violi, F., & Venditti, M. (2014) · Internal and Emergency Medicine · doi:10.1007/s11739-014-1077-4 · Cited by 30
Management of Invasive Candidiasis in the Intensive Care Unit
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Drugs · doi:10.2165/10898550-000000000-00000 · Cited by 30
Applications of yeast in drug discovery
Ma, D. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8308-5_3 · Cited by 30
Lupetti, A., Brouwer, C. P. J. M., Dogterom-Ballering, H. C. M., Senesi, S., Campa, M., van Dissel, J. T., & Nibbering, P. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh385 · Cited by 30
Comparison of Candida albicans strain types among isolates from three countries
Takakura, S., Ichiyama, S., Bain, J. M., Davidson, A. D., Jacobsen, M. D., Shaw, D. J., Gow, N. A. R., & Odds, F. C. (2008) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.11.002 · Cited by 30
Qavi, A., Segal‐Maurer, S., Mariano, N., Urban, C. M., Rosenberg, C. R., Burns, J. M., Chiang, T., Maurer, J., & Rahal, J. J. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502488 · Cited by 30
Basso, P., Dang, E. V., Urisman, A., Cowen, L. E., Madhani, H. D., & Noble, S. M. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.10.004 · Cited by 29
Marschall, J., Piccirillo, M. L., Fraser, V. J., Doherty, J. A., Warren, D. K., & Program, F. T. C. P. E. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/678503 · Cited by 29
Milazzo, L., Peri, A. M., Mazzali, C., Grande, R., Cazzani, C., Ricaboni, D., Castelli, A., Raimondi, F., Magni, C. F., Galli, M., et al. (2014) · Mycopathologia · doi:10.1007/s11046-014-9786-9 · Cited by 29
Huttunen, R., Åttman, E., Aittoniemi, J., Outinen, T. K., Syrjänen, J., Kärki, T., & Lyytikäinen, O. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.956791 · Cited by 29
Antimicrobial and antioxidant activities of Momordica charantia from Turkey
Asan-Ozusaglam, M., & Karakoca, K. (2013) · AFRICAN JOURNAL OF BIOTECHNOLOGY · Cited by 29
Chattopadhyay, R. R., Bhattacharyya, S. K., Medda, C., Chanda, S., & Bag, A. (2009) · Brazilian Archives of Biology and Technology · doi:10.1590/s1516-89132009000500009 · Cited by 29
Tsitsopoulos, P. P., Iosifidis, Ε., Antachopoulos, C., Anestis, D. M., Karantani, E., Karyoti, A., Papaevangelou, G., Kyriazidis, E., Roilides, E., & Tsonidis, C. A. (2016) · Acta Neurochirurgica · doi:10.1007/s00701-016-2890-5 · Cited by 29
Metadata
- Authors
- Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Wenzel, Richard P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 239-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157766752
- Cited by
- 1,387
- References
- 16
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 37 · 2018: 31 · 2017: 36 · 2016: 41 · 2015: 33 · 2014: 56 · 2013: 55 · 2012: 55
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial bloodstream infection, hospital-acquired bacteremia, coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus, Gram-positive bacteria, Gram-negative bacteria, fungemia, methicillin resistance, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, Streptococcus viridans, neutropenia, intensive care unit, empirical antibiotic therapy, infection surveillance
- MeSH terms
- Candida, Cross Infection, Gram-Negative Bacteria, Gram-Positive Bacteria, Hospitals, Humans, Neutropenia, Staphylococcus, United States, Fungemia, Bacteremia, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.